Daniel Grosslight

Q: What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of 95.60168325364867.

Q: What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of 10.421108735759526.

Citigroup | Healthcare

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector. Ranked #1613 out of 4508 analysts, they have issued 27 stock ratings with a success rate of 95.60% and an average return of 10.42%.

Daniel Grosslight has a well-established track record, with 27 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 95.60% and an average return of 10.42%, underscoring their expertise and ability to identify winning opportunities for investors.

#1613

Out of 4508

Total Ratings

+95.60%

Success Rate

+10.42%

Average Return

Recent Ratings Analysis

WAY

Buy

Jan 09, 2026

Target

$49.00

Current

$34.50

Performance

0.00%

Daniel Grosslight rated WAY as Buy on Jan 09, 2026, setting a price target of 49. Shares have remained stable near 34.5, leaving the 49 target still in play.

EVH

Buy

Jan 09, 2026

Target

$9.50

Current

$4.17

Performance

0.00%

On Jan 09, 2026, EVH was given a Buy rating by Daniel Grosslight, with a target price of 9.5. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

GDRX

Buy

Jan 09, 2026

Target

$5.00

Current

$2.80

Performance

0.00%

GDRX received a Buy rating from Daniel Grosslight on Jan 09, 2026, aiming for 5. Price action was muted, as shares hovered around 2.8 despite the bullish outlook.

HCAT

Hold

Jan 09, 2026

Target

$3.25

Current

$2.47

Performance

0.00%

On Jan 09, 2026, Daniel Grosslight published a Neutral outlook on HCAT, with a target of 3.25. Sideways action left the Hold view intact, with no major move since 2.47.

PHR

Buy

Jan 09, 2026

Target

$29.00

Current

$17.23

Performance

0.00%

Daniel Grosslight on Jan 09, 2026 assigned PHR a Buy rating, with a price target of 29. The recommendation remains pending validation as shares consolidate around 17.23.

TDOC

Hold

Jan 09, 2026

Target

$10.00

Current

$7.46

Performance

0.00%

On Jan 09, 2026, Daniel Grosslight reaffirmed TDOC with a Neutral rating, targeting 10. The neutral call matched muted market action of 0.00%.

CAH

Buy

Jan 09, 2026

Target

$244.00

Current

$201.11

Performance

0.00%

CAH was rated Buy by Daniel Grosslight on Jan 09, 2026, with a price objective of 244. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

CTEV

Buy

Jan 09, 2026

Target

$80.00

Current

$28.94

Performance

0.00%

On Jan 09, 2026, Daniel Grosslight initiated coverage on CTEV with a Buy rating and target of 80. Neutral price movement of 0.00% leaves room for interpretation.

MCK

Buy

Sep 24, 2025

Target

$860.00

Current

$816.06

Performance

7.29%

Daniel Grosslight issued a Buy recommendation for MCK on Sep 24, 2025, price target set at 860. Investors following the Buy call captured upside momentum, with shares now at 816.06.

OMI

Buy

Aug 12, 2025

Target

$7.00

Current

$2.15

Performance

-60.69%

On Aug 12, 2025, OMI was evaluated by Daniel Grosslight, who gave a Buy rating and target of 7. Investors saw limited payoff as shares fell short of the 7 target.

AGL

Hold

Aug 06, 2025

Target

$1.00

Current

$0.99

Performance

11.47%

Daniel Grosslight rated AGL as Neutral on Aug 06, 2025, setting a price target of 1. Despite the Hold call, shares climbed 11.47% to 0.9921, revealing unexpected momentum.

HIMS

Sell

Mar 06, 2025

Target

$27.00

Current

$31.69

Performance

-7.85%

On Mar 06, 2025, HIMS was given a Sell rating by Daniel Grosslight, with a target price of 27. The bearish stance was challenged as the stock rebounded from 31.69.

MPLN

Hold

Jan 10, 2025

Target

$12.50

Current

$23.15

Performance

81.85%

MPLN received a Neutral rating from Daniel Grosslight on Jan 10, 2025, aiming for 12.5. Investors saw gains of 81.85% that the cautious stance didn’t fully capture.

Frequency Asked Questions

Who is Daniel Grosslight?

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector.

What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of +95.60%.

How many ratings has Daniel Grosslight issued?

Daniel Grosslight has issued 27 stock ratings so far.

What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of +10.42%.

What is Daniel Grosslight's ranking?

Daniel Grosslight is ranked #1613 out of 4508 analysts.

What types of ratings does Daniel Grosslight give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Daniel Grosslight?

You can follow Daniel Grosslight by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Daniel Grosslight?

Their latest rating was a Buy on WAY issued on 2026-01-09.